PT1022960E - Composicao para a supressao dos sintomas de abstinencia e da vontade de ingestao de alcool em alcoolicos e para a prevencao do abuso de alcool em individuos saudaveis - Google Patents

Composicao para a supressao dos sintomas de abstinencia e da vontade de ingestao de alcool em alcoolicos e para a prevencao do abuso de alcool em individuos saudaveis

Info

Publication number
PT1022960E
PT1022960E PT98946703T PT98946703T PT1022960E PT 1022960 E PT1022960 E PT 1022960E PT 98946703 T PT98946703 T PT 98946703T PT 98946703 T PT98946703 T PT 98946703T PT 1022960 E PT1022960 E PT 1022960E
Authority
PT
Portugal
Prior art keywords
alcohol
alcoholics
composition
symptoms
abstinence
Prior art date
Application number
PT98946703T
Other languages
English (en)
Portuguese (pt)
Inventor
Claudio Cavazza
Aldo Fassi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT1022960E publication Critical patent/PT1022960E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Addiction (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PT98946703T 1997-10-03 1998-09-18 Composicao para a supressao dos sintomas de abstinencia e da vontade de ingestao de alcool em alcoolicos e para a prevencao do abuso de alcool em individuos saudaveis PT1022960E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo

Publications (1)

Publication Number Publication Date
PT1022960E true PT1022960E (pt) 2002-12-31

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98946703T PT1022960E (pt) 1997-10-03 1998-09-18 Composicao para a supressao dos sintomas de abstinencia e da vontade de ingestao de alcool em alcoolicos e para a prevencao do abuso de alcool em individuos saudaveis

Country Status (27)

Country Link
US (1) US6255346B1 (enExample)
EP (1) EP1022960B1 (enExample)
JP (1) JP2001518484A (enExample)
KR (2) KR100530368B1 (enExample)
CN (1) CN1092939C (enExample)
AT (1) ATE220860T1 (enExample)
AU (1) AU730740B2 (enExample)
BG (1) BG64363B1 (enExample)
BR (1) BR9812604A (enExample)
CA (1) CA2305598C (enExample)
CZ (1) CZ291801B6 (enExample)
DE (1) DE69806788T2 (enExample)
DK (1) DK1022960T3 (enExample)
EA (1) EA002177B1 (enExample)
EE (1) EE04036B1 (enExample)
ES (1) ES2180200T3 (enExample)
HU (1) HUP0004336A3 (enExample)
IS (1) IS2234B (enExample)
IT (1) IT1295408B1 (enExample)
MX (1) MXPA00003232A (enExample)
NO (1) NO20001688L (enExample)
NZ (1) NZ503663A (enExample)
PL (1) PL189663B1 (enExample)
PT (1) PT1022960E (enExample)
SK (1) SK283384B6 (enExample)
UA (1) UA66807C2 (enExample)
WO (1) WO1999017623A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
RU2300376C2 (ru) * 2005-05-11 2007-06-10 МУЗ Городская клиническая больница №3 им. М.А. Подгорбунского г.Кемерово Способ лечения при алкогольном делирии
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
US20230149338A1 (en) * 2020-04-14 2023-05-18 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
EP0776604B1 (en) * 1995-12-01 2002-01-23 Unilever N.V. Microwavable crispy bread-rolls
DK0793962T3 (da) * 1996-03-04 2000-05-22 Sigma Tau Ind Farmaceuti Lægemiddel indeholdende et carnitinderivat til behandling af arteriosclerosis obliterans

Also Published As

Publication number Publication date
EE200000235A (et) 2001-06-15
EP1022960A1 (en) 2000-08-02
WO1999017623A1 (en) 1999-04-15
IS5416A (is) 2000-03-24
EA002177B1 (ru) 2002-02-28
EP1022960B1 (en) 2002-07-24
CZ20001207A3 (cs) 2000-11-15
KR100560097B1 (ko) 2006-03-13
NO20001688L (no) 2000-06-02
EA200000377A1 (ru) 2000-10-30
HUP0004336A2 (hu) 2001-05-28
NO20001688D0 (no) 2000-03-31
NZ503663A (en) 2001-11-30
CA2305598A1 (en) 1999-04-15
HUP0004336A3 (en) 2001-07-30
US6255346B1 (en) 2001-07-03
PL339621A1 (en) 2001-01-02
CA2305598C (en) 2007-11-20
EE04036B1 (et) 2003-06-16
BR9812604A (pt) 2000-08-01
ATE220860T1 (de) 2002-08-15
DE69806788D1 (de) 2002-08-29
MXPA00003232A (es) 2004-03-10
DK1022960T3 (da) 2002-11-04
DE69806788T2 (de) 2003-04-03
CZ291801B6 (cs) 2003-05-14
BG64363B1 (bg) 2004-12-30
KR100530368B1 (ko) 2005-11-22
IT1295408B1 (it) 1999-05-12
CN1092939C (zh) 2002-10-23
JP2001518484A (ja) 2001-10-16
SK4762000A3 (en) 2000-10-09
KR20010030928A (ko) 2001-04-16
AU730740B2 (en) 2001-03-15
AU9366098A (en) 1999-04-27
HK1028714A1 (en) 2001-03-02
CN1276704A (zh) 2000-12-13
PL189663B1 (pl) 2005-09-30
UA66807C2 (uk) 2004-06-15
KR20050088499A (ko) 2005-09-06
BG104286A (en) 2000-11-30
ES2180200T3 (es) 2003-02-01
IS2234B (is) 2007-04-15
SK283384B6 (sk) 2003-06-03
ITRM970594A1 (it) 1999-04-03

Similar Documents

Publication Publication Date Title
PT1022960E (pt) Composicao para a supressao dos sintomas de abstinencia e da vontade de ingestao de alcool em alcoolicos e para a prevencao do abuso de alcool em individuos saudaveis
Bhattacharya et al. Healing properties of some Indian medicinal plants against indomethacin-induced gastric ulceration of rats
Percival Use of Echinacea in medicine
BR9815302A (pt) Método para diminuir a concentração de colesterol ldl e aumentar a concentração de colesterol hdl no sangue para reduzir o risco de aterosclerose e doença vascular
WO2003013549A3 (de) Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern
JP2008508219A (ja) コラーゲンに基づく生理活性
PT1337236E (pt) Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas
ATE128606T1 (de) Gluciden enthaltend zusammenstellungen zur diät und therapie und ihre verwendungen.
KR930021110A (ko) 소나무 추출물의 기호성 개선 방법 및 이 방법에 의하여 제조되는 경구 섭취물
JP2008543745A (ja) 循環器系危険因子及びシンドロームxを誘発する代謝性危険因子を改善するための方法及び組成物
NO20021640L (no) Sammensetning til forebygging og/eller behandling av kretslöpsykdommer som omfatter derivater av L-karnitin ogekstrakter av Gingo biloba
McKenna et al. Scurvy occurring in a teenager
JP2005104921A (ja) イチョウ葉からの新規抽出物及びその製法
BRPI0411436A (pt) composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
JP4706174B2 (ja) α−グルコシダーゼ阻害剤
Vargas et al. Getting to the Root (Acorns calamus) of the Problem
US20040018990A1 (en) Treatment of obesity
JP2003226650A (ja) 医薬用組成物
Davies et al. Adverse effects and toxicity of nutraceuticals
WO2001003683A3 (en) Cardioactive composition comprising l-carnitine and its derivatives and crataegus extracts
US20040122054A1 (en) Alpha glucosidase inhibitor use
JP4604506B2 (ja) α−グルコシダーゼ阻害剤
Uriah et al. In vitro Antioxidant and Anti-hepatotoxic Activities of Roots of Potentilla fulgens Wall: An Ethno Medicinal Plant of North Eastern India
JP2006348054A (ja) リパーゼ阻害剤
Cerrato Ginseng doesn't improve one's mood